scout
|Videos|October 26, 2017

Dr. Hoffman-Censits Discusses the Future Treatment of Bladder Cancer

Jean Hoffman-Censits, MD, associate professor of Medical Oncology, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, discusses the future treatment landscape of bladder cancer.

Jean Hoffman-Censits, MD, associate professor of medical oncology, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, discusses the future treatment landscape of bladder cancer.

Suitable and tolerable treatments such as immunotherapy agents have changed the field of bladder cancer, says Hoffman-Censits, especially for patients who are ineligible for cisplatin.

Looking ahead, Hoffman-Censits says that recent advances with targeted therapy and immunotherapy will hopefully lead to longer survival and higher rates of bladder conservation.

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME